A CASE-BASED PATHOLOGY PERSPECTIVE TO BIOMARKER TESTING IN ADVANCED NSCLC
Chung-Che (Jeff) Chang, MD, PhD
Hematology and Molecular Pathology Labs,
Florida Hospital Cancer Institute,
Join Dr. Chang as he uses a case-based approach to discuss strategies to ensure that there is sufficient tissue for histology and molecular characterization in advanced non-small cell lung cancer (NSCLC), and reviews some best practices for optimizing biomarker testing.